# CSE-HITRUST-PRIVACY-NO-USE-LIMITATION-003

**Use Limitation Missing**

## Signal Overview

| Field | Value |
|-------|-------|
| Identifier | `CSE-HITRUST-PRIVACY-NO-USE-LIMITATION-003` |
| Domain | HITRUST |
| Category | PRIVACY |
| Status | Active |
| Introduced In | 1.0.0 |

## Description

Controls to limit the use of personal or protected health information (PHI) to specified, legitimate purposes have not been established or enforced.

This signal indicates the absence of technical or procedural controls that restrict how personal information is used within the organization. Use limitation ensures that information collected for one purpose is not used for unrelated purposes without appropriate authorization or consent. This principle is fundamental to privacy protection and data minimization.

## Applicability

- Healthcare organizations subject to HIPAA
- Business associates handling PHI
- Organizations pursuing HITRUST certification
- Health information exchanges (HIEs)
- Healthcare analytics and research organizations
- Medical device manufacturers
- Healthcare SaaS and cloud service providers
- Insurance companies processing health claims

## Examples (Non-Normative)

### Database Access Without Purpose Controls

```sql
-- User granted broad access without purpose limitation
GRANT SELECT, INSERT, UPDATE ON patient_records TO 'analytics_user';
-- No enforcement of purpose-specific access
```

### API Without Use Case Restriction

```python
# API endpoint without purpose validation
@app.route('/api/patient-data/<patient_id>')
def get_patient_data(patient_id):
    # Returns all data without checking intended use
    return database.get_all_patient_info(patient_id)
    # No validation of use purpose or authorization
```

### Data Export Without Purpose Documentation

```yaml
# Data export configuration lacking purpose controls
data_exports:
  - destination: "marketing_database"
    data_types: ["demographics", "diagnosis", "medications"]
    purpose: null  # No purpose specified or enforced
    restrictions: []
```

### Analytics Platform Without Use Boundaries

```json
{
  "analytics_access": {
    "user_role": "data_scientist",
    "datasets": ["all_patient_records"],
    "allowed_purposes": null,
    "use_restrictions": [],
    "approval_required": false
  }
}
```

## What This Signal Does NOT Assert

- Whether use limitation policies exist in documentation
- The effectiveness of informal use controls
- Whether the organization is compliant or non-compliant with HITRUST
- The specific purposes for which data should be limited
- Whether data is actually being misused

## HITRUST Context (Informative)

- **Control Domain**: 13 - Privacy Practices
- **Control Reference**: 13.c
- **Assessment Types**: e1, i1, r2
- **Maturity Levels**: 1-5

This signal is relevant to HITRUST CSF v11 requirements for use limitation that:
- Restricts information use to specified legitimate purposes
- Enforces purpose-based access controls
- Prevents secondary use without authorization
- Implements technical controls for use restriction
- Monitors and audits information usage
- Ensures data minimization principles

These references are informative and do not constitute compliance guidance.

## Related Signals

- `CSE-HITRUST-PRIVACY-NO-CONSENT-002` - Consent management missing
- `CSE-HITRUST-ACCESS-NO-PRIVILEGE-MANAGEMENT-003` - Privilege management not implemented
- `CSE-HITRUST-PRIVACY-NO-DISCLOSURE-TRACKING-005` - Disclosure tracking missing
- `CSE-HIPAA-PRIVACY-NO-MINIMUM-NECESSARY-001` - HIPAA minimum necessary requirements (if defined)

## Notes

Detection of this signal typically involves:

- Review of access control policies and configurations
- Examination of role-based access control (RBAC) implementations
- Analysis of data access logging and monitoring
- Verification of purpose-of-use attributes in access requests
- Assessment of data sharing and export controls
- Review of API and database access restrictions

The presence of this signal indicates a privacy control gap that could lead to inappropriate use of personal information and regulatory non-compliance.
